Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Investor patience tested as pharmaceutical stocks take a tumble
06:07am, Wednesday, 01'st Nov 2023
The Health Care Select Sector SPDR Fund NYSEARCA: XLV was down 3.81% in the past month and 8.03% in the past three months. The latest round of pharmaceutical stock earnings isn't helping sector perfor
Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
07:22pm, Tuesday, 31'st Oct 2023
Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple inflammatory diseases.
U.S. FDA approves Amgen's biosimilar vesrion of J&J's Stelara
06:32pm, Tuesday, 31'st Oct 2023
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis treatment Stelara for multiple inflammatory diseases.
Amgen's obesity drug plans, outlook for 2024
03:41pm, Tuesday, 31'st Oct 2023
Amgen (AMGN) reported third-quarter earnings that beat expectations and raised its full-year revenue guidance. The company recently completed its acquisition of Horizon Therapeutics, which brings its
Amgen (AMGN) Beats on Q3 Earnings Beat, Lags Sales, Ups View
12:46pm, Tuesday, 31'st Oct 2023
Amgen (AMGN) beats Q3 estimates for earnings but misses on sales. Following the acquisition of Horizon Therapeutics, it raises earnings and sales guidance for 2023.
Amgen (AMGN) Q3 Earnings Top Estimates
09:46am, Tuesday, 31'st Oct 2023
Amgen (AMGN) came out with quarterly earnings of $4.96 per share, beating the Zacks Consensus Estimate of $4.65 per share. This compares to earnings of $4.70 per share a year ago.
Amgen stock unmoved by earnings beat
08:46am, Tuesday, 31'st Oct 2023
In contrast to market expectations, shares of Amgen, Inc. (NASDAQ:AMGN) remained flat even as the biotechnology giant exceeded third-quarter earnings estimates and once again raised its financial gui
Amgen Boosts Revenue Guidance. But the Stock Trades Lower.
08:04am, Tuesday, 31'st Oct 2023
The biotechnology company beat third-quarter adjusted earnings estimates but fell a bit short on sales.
Amgen's stock jumps premarket after earnings beat and company again raises guidance
07:19am, Tuesday, 31'st Oct 2023
Amgen Inc.'s stock AMGN, +0.62% rose 2.9% in premarket trade Tuesday, after the biotech blew past earnings estimates for the third quarter and again raised its guidance. The company posted net income
Amgen third-quarter sales rise 5%; profit up before charge
07:10am, Tuesday, 31'st Oct 2023
Amgen , which earlier this month acquired Horizon Therapeutics for $27.8 billion, on Tuesday said its third-quarter product sales rose 5% as double-digit volume growth was offset by lower prices.
2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now
06:30am, Sunday, 29'th Oct 2023
Dividend stocks haven't been top performers in 2023. Over lengthy holding periods, though, high-quality dividend stocks tend to deliver above-average returns.
Amgen (AMGN) to Report Q3 Earnings: Will It Beat Estimates?
09:01am, Wednesday, 25'th Oct 2023
Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Amgen (AMGN) Outperforms Broader Market: What You Need to Know
07:33pm, Tuesday, 24'th Oct 2023
In the latest trading session, Amgen (AMGN) closed at $276.12, marking a +1.12% move from the previous day.
Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts
03:08pm, Tuesday, 24'th Oct 2023
When massive acquisitions take place, job cuts typically follow. Such is the case with Amgen (NASDAQ: AMGN ) today.
GSK Gears Up for Q3 Earnings: Will It Surpass Estimates?
09:01am, Tuesday, 24'th Oct 2023
We expect GSK's specialty products like Cabenuva, Juluca, Dovato, Bexsero, Trelegy Ellipta and Shingrix to drive third-quarter sales performance.
